Lenalidomide for Patients With Myelofibrosis (MF)

NCT00352794 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Myelofibrosis

Interventions

DRUG: Lenalidomide
DRUG: Prednisone

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]